Interleukin-7 receptor alpha mutational activation... - BV FAPESP
Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Interleukin-7 receptor alpha mutational activation can initiate precursor B-cell acute lymphoblastic leukemia

Full text
Author(s):
Show less -
Almeida, Afonso R. M. [1] ; Neto, Joao L. [1] ; Cachucho, Ana [1] ; Euzebio, Mayara [2, 1] ; Meng, Xiangyu [3] ; Kim, Rathana [4, 5] ; Fernandes, Marta B. [1] ; Raposo, Beatriz [1] ; Oliveira, Mariana L. [1] ; Ribeiro, Daniel [1] ; Fragoso, Rita [1] ; Zenatti, Priscila P. [2] ; Soares, Tiago [1] ; de Matos, Mafalda R. [1] ; Correa, Juliana Ronchi [2] ; Duque, Mafalda [1] ; Roberts, Kathryn G. [6, 7] ; Gu, Zhaohui [6, 7] ; Qu, Chunxu [6, 7] ; Pereira, Clara [8] ; Pyne, Susan [9] ; Pyne, Nigel J. [9] ; Barreto, Vasco M. [10] ; Bernard-Pierrot, Isabelle [3] ; Clappier, Emannuelle [4, 5] ; Mullighan, Charles G. [6, 7] ; Grosso, Ana R. [11] ; Yunes, J. Andres [2] ; Barata, Joao T. [1]
Total Authors: 29
Affiliation:
Show less -
[1] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon - Portugal
[2] Ctr Infantil Boldrini, Campinas, SP - Brazil
[3] PSL Res Univ, Inst Curie, Equipe Labellisee Ligue Canc, UMR144, Paris - France
[4] St Louis Hosp, AP HP, Hematol Lab, Paris - France
[5] Univ Paris, St Louis Res Inst, Ctr Natl Rech Sci CNRS, Unite Mixte Rech UMR 7212, INSERM U944, Paris - France
[6] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN - USA
[7] St Jude Childrens Res Hosp, Hematol Malignancies Program, Memphis, TN 38105 - USA
[8] Univ Dublin, Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2 - Ireland
[9] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci SIPBS, Glasgow, Lanark - Scotland
[10] Univ Nova Lisboa, NOVA Med Sch, CEDOC Chron Dis Res Ctr, DNA Breaks Lab, Fac Ciencias Med, Lisbon - Portugal
[11] Univ NOVA Lisboa, Fac Ciencias & Tecnol, Dept Ciencias Vida, UCIBIO, Caparica - Portugal
Total Affiliations: 11
Document type: Journal article
Source: NATURE COMMUNICATIONS; v. 12, n. 1 DEC 14 2021.
Web of Science Citations: 0
Abstract

Interleukin-7 receptor alpha (IL7Ra) is important for lymphoid cell development but its role in leukaemogenesis is not clear. Here, the authors generate a knock-in murine model to show that activating mutations in IL7Ra can initiate precursor B-cell acute lymphoblastic leukaemia. Interleukin-7 receptor alpha (encoded by IL7R) is essential for lymphoid development. Whether acute lymphoblastic leukemia (ALL)-related IL7R gain-of-function mutations can trigger leukemogenesis remains unclear. Here, we demonstrate that lymphoid-restricted mutant IL7R, expressed at physiological levels in conditional knock-in mice, establishes a pre-leukemic stage in which B-cell precursors display self-renewal ability, initiating leukemia resembling PAX5 P80R or Ph-like human B-ALL. Full transformation associates with transcriptional upregulation of oncogenes such as Myc or Bcl2, downregulation of tumor suppressors such as Ikzf1 or Arid2, and major IL-7R signaling upregulation (involving JAK/STAT5 and PI3K/mTOR), required for leukemia cell viability. Accordingly, maximal signaling drives full penetrance and early leukemia onset in homozygous IL7R mutant animals. Notably, we identify 2 transcriptional subgroups in mouse and human Ph-like ALL, and show that dactolisib and sphingosine-kinase inhibitors are potential treatment avenues for IL-7R-related cases. Our model, a resource to explore the pathophysiology and therapeutic vulnerabilities of B-ALL, demonstrates that IL7R can initiate this malignancy. (AU)

FAPESP's process: 12/03660-9 - Development of therapeutics monoclonal antibodies against mutant IL7R homodimer in Acute Lymphoblastic Leukemia
Grantee:Priscila Pini Zenatti Salles
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 17/02400-7 - Development of an animal model of precursor B-cell acute lymphoblastic leukemia with the oncogenic IL7R mutation
Grantee:Juliana Ronchi Corrêa
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 12/12802-1 - Cooperating mutations, functional studies and antibodies against the mutant IL7R in acute lymphoblastic leukemia
Grantee:José Andrés Yunes
Support Opportunities: Regular Research Grants
FAPESP's process: 17/10653-2 - In vivo leukemogenic potential of the mutant CD2-CRE/IL7R
Grantee:Mayara Ferreira Euzébio
Support Opportunities: Scholarships abroad - Research Internship - Master's degree
FAPESP's process: 16/07724-2 - In vivo leukemogenic potential of the mutant IL-7R
Grantee:Mayara Ferreira Euzébio
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 14/20015-5 - Aberrant IL7R signaling in leukemogenesis: from the basics to potential therapeutics
Grantee:José Andrés Yunes
Support Opportunities: Regular Research Grants